Add-on Clioquinol in Drug-resistant Childhood Epilepsy: an Exploratory Study

Clinical trial NCT05727943 · UNKNOWN

Trial details

NCT number: NCT05727943
Sponsor: KU Leuven
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Epilepsy Intractable

Start date: 2022-03-01
Primary completion: 2023-12-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.